Processes for the preparation of 5 - lipooxygenase activating protein inhibitors and their intermediates

Details for Australian Patent Application No. 2010314177 (hide)

Owner Panmira Pharmaceuticals LLC Glaxo Group Limited

Inventors Crawford, Claire Frances; Garcia, Sandrine; Graham, Jonathan Paul; Harling, Sandra Jane; Henley, Nicholas Paul; Hermitage, Stephen Andrew; Hutchinson, John Howard; Keel, Trevor Raymond; Kennedy, Andrew; Mason, Andrew McMurtrie; Scott, Mark Simon; Smith, Neil Michael; Stock, Nicholas Simon; Tateno, Yuichi; Trouw, Leontine Saskia; Turner, Peter Graham; Wallis, Christopher John; Willacy, Robert David

Agent Davies Collison Cave

Pub. Number AU-A-2010314177

PCT Pub. Number WO2011/054783

Priority 61/366,178 21.07.10 US; 61/260,453 12.11.09 US; 61/257,479 03.11.09 US

Filing date 2 November 2010

Wipo publication date 12 May 2011

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

10 May 2012 PCT application entered the National Phase

  PCT publication WO2011/054783 Priority application(s): WO2011/054783

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010314181-Method for producing shrink films

2010314174-Closable throughflow member